Skip to Content
Merck

Loss of Bright/ARID3a function promotes developmental plasticity.

Stem cells (Dayton, Ohio) (2010-08-04)
Guangyu An, Cathrine A Miner, Jamee C Nixon, Paul W Kincade, James Bryant, Philip W Tucker, Carol F Webb
ABSTRACT

B-cell regulator of immunoglobulin heavy chain transcription (Bright)/ARID3a, an A+T-rich interaction domain protein, was originally discovered in B lymphocyte lineage cells. However, expression patterns and high lethality levels in knockout mice suggested that it had additional functions. Three independent lines of evidence show that functional inhibition of Bright results in increased developmental plasticity. Bright-deficient cells from two mouse models expressed a number of pluripotency-associated gene products, expanded indefinitely, and spontaneously differentiated into cells of multiple lineages. Furthermore, direct knockdown of human Bright resulted in colonies capable of expressing multiple lineage markers. These data suggest that repression of this single molecule confers adult somatic cells with new developmental options.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Nestin Antibody, clone rat-401, clone rat-401, Chemicon®, from mouse
Sigma-Aldrich
Anti-Stage-Specific Embryonic Antigen-1 Antibody, clone MC-480, clone MC-480, Chemicon®, from mouse
Sigma-Aldrich
Anti-SOX-2 Antibody, clone 6F1.2, Chemicon®, from mouse